Literature DB >> 17035276

Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.

David McKeag1, Carol Lane, John H Lazarus, Lelio Baldeschi, Kostas Boboridis, A Jane Dickinson, A Iain Hullo, George Kahaly, Gerry Krassas, Claudio Marcocci, Michele Marinò, Maarten P Mourits, Marco Nardi, Christopher Neoh, Jacques Orgiazzi, Petros Perros, Aldo Pinchera, Susanne Pitz, Mark F Prummel, Maria S Sartini, Wilmar M Wiersinga.   

Abstract

BACKGROUND: This study was performed to determine clinical features of dysthyroid optic neuropathy (DON) across Europe.
METHODS: Forty seven patients with DON presented to seven European centres during one year. Local protocols for thyroid status, ophthalmic examination and further investigation were used. Each eye was classified as having definite, equivocal, or no DON.
RESULTS: Graves' hyperthyroidism occurred in the majority; 20% had received radioiodine. Of 94 eyes, 55 had definite and 17 equivocal DON. Median Clinical Activity Score was 4/7 but 25% scored 3 or less, indicating severe inflammation was not essential. Best corrected visual acuity was 6/9 (Snellen) or worse in 75% of DON eyes. Colour vision was reduced in 33 eyes, of which all but one had DON. Half of the DON eyes had normal optic disc appearance. In DON eyes proptosis was > 21 mm (significant) in 66% and visual fields abnormal in 71%. Orbital imaging showed apical muscle crowding in 88% of DON patients. Optic nerve stretch and fat prolapse were infrequently reported.
CONCLUSION: Patients with DON may not have severe proptosis and orbital inflammation. Optic disc swelling, impaired colour vision and radiological evidence of apical optic nerve compression are the most useful clinical features in this series.

Entities:  

Mesh:

Year:  2006        PMID: 17035276      PMCID: PMC1994756          DOI: 10.1136/bjo.2006.094607

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  17 in total

1.  Results of transmedial-canthal ethmoidal decompression for severe dysthyroid optic neuropathy.

Authors:  K Ohtsuka; Y Nakamura
Journal:  Jpn J Ophthalmol       Date:  1999 Sep-Oct       Impact factor: 2.447

Review 2.  Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment.

Authors:  A J Dickinson; P Perros
Journal:  Clin Endocrinol (Oxf)       Date:  2001-09       Impact factor: 3.478

3.  Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience.

Authors:  Mark F Prummel; Annemieke Bakker; Wilmar M Wiersinga; Lelio Baldeschi; Maarten P Mourits; Pat Kendall-Taylor; Petros Perros; Chris Neoh; A Jane Dickinson; John H Lazarus; Carol M Lane; Armin E Heufelder; George J Kahaly; Suzanne Pitz; Jacques Orgiazzi; Alain Hullo; Aldo Pinchera; Claudio Marcocci; Maria S Sartini; Roberto Rocchi; Marco Nardi; Gerry E Krassas; A Halkias
Journal:  Eur J Endocrinol       Date:  2003-05       Impact factor: 6.664

4.  Management of dysthyroid optic neuropathy.

Authors:  T G Klingele; W M Hart; R M Burde
Journal:  Ophthalmologica       Date:  1977       Impact factor: 3.250

5.  Visual evoked potentials in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy.

Authors:  Gennaro Ambrosio; Giuseppe Ferrara; Raffaella Vitale; Rocco De Marco
Journal:  Doc Ophthalmol       Date:  2003-03       Impact factor: 2.379

6.  Dysthyroid optic neuropathy. Clinical profile and rationale for management.

Authors:  J D Trobe; J S Glaser; P Laflamme
Journal:  Arch Ophthalmol       Date:  1978-07

Review 7.  Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy.

Authors:  R S Bahn; C A Gorman
Journal:  Endocrinol Metab Clin North Am       Date:  1987-06       Impact factor: 4.741

8.  CT scan evidence of dysthyroid optic neuropathy.

Authors:  JoAnn A Giaconi; Michael Kazim; Tae Rho; Charles Pfaff
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2002-05       Impact factor: 1.746

9.  Optic neuropathy of Graves disease: results of transantral orbital decompression and long-term follow-up in 215 patients.

Authors:  Cacia V Soares-Welch; Vahab Fatourechi; George B Bartley; Charles W Beatty; Colum A Gorman; Rebecca S Bahn; Erik J Bergstralh; Cathy D Schleck; James A Garrity
Journal:  Am J Ophthalmol       Date:  2003-09       Impact factor: 5.258

Review 10.  Graves' ophthalmopathy: state of the art and perspectives.

Authors:  L Bartalena; W M Wiersinga; A Pinchera
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

View more
  68 in total

1.  Quantification of orbital apex crowding for screening of dysthyroid optic neuropathy using multidetector CT.

Authors:  A C P Gonçalves; L N Silva; E M M S Gebrim; M L R Monteiro
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-22       Impact factor: 3.825

2.  Dysthyroid optic neuropathy: a clinical diagnosis or a definable entity?

Authors:  Colin M Dayan; Margaret R Dayan
Journal:  Br J Ophthalmol       Date:  2007-04       Impact factor: 4.638

Review 3.  Graves orbitopathy: a perspective.

Authors:  Petros Perros; Gerasimos E Krassas
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

4.  Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique.

Authors:  Raymond S Douglas; Angelo Tsirbas; Mark Gordon; Diana Lee; Nicole Khadavi; Helene Chokron Garneau; Robert A Goldberg; Kenneth Cahill; Peter J Dolman; Victor Elner; Steve Feldon; Mark Lucarelli; Jimmy Uddin; Michael Kazim; Terry J Smith; Dinesh Khanna
Journal:  Arch Ophthalmol       Date:  2009-09

5.  [Clinical and neuroradiological diagnostics in Graves' orbitopathy].

Authors:  F Beisse; C Pieh-Beisse; W A Lagrèze; C Hader
Journal:  Ophthalmologe       Date:  2011-05       Impact factor: 1.059

6.  Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy.

Authors:  K A Ponto; T Diana; H Binder; N Matheis; S Pitz; N Pfeiffer; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2015-03-04       Impact factor: 4.256

7.  Orbital decompression surgery for the treatment of Graves' ophthalmopathy: comparison of different techniques and long-term results.

Authors:  Mehmet Ozgur Cubuk; Onur Konuk; Mehmet Unal
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

8.  Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves' orbitopathy: relation with the clinical features.

Authors:  Onur Konuk; Zafer Onaran; Suna Ozhan Oktar; Cem Yucel; Mehmet Unal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-16       Impact factor: 3.117

9.  Risk factors associated with the severity of thyroid-associated orbitopathy in Korean patients.

Authors:  Ji Hwan Lee; Sang Yeul Lee; Jin Sook Yoon
Journal:  Korean J Ophthalmol       Date:  2010-10-05

10.  Update on thyroid eye disease and management.

Authors:  Erick D Bothun; Ryan A Scheurer; Andrew R Harrison; Michael S Lee
Journal:  Clin Ophthalmol       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.